SPTX (Seaport Therapeutics) Interest Expense: $ Mil (TTM As of Dec. 2025)


SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $21.43
! 1 Warning Sign
View Full Analysis

What is Seaport Therapeutics Interest Expense?

Seaport Therapeutics SPTX +10.37% 11 Interest Expense is $ Mil as of Dec. 2025. GuruFocus rates SPTX with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Seaport Therapeutics's interest expense for the six months ended in Dec. 2025 was $ 0.00 Mil. Seaport Therapeutics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Seaport Therapeutics's Operating Income for the six months ended in Dec. 2025 was $ -87.29 Mil. Seaport Therapeutics's Interest Expense for the six months ended in Dec. 2025 was $ 0.00 Mil. GuruFocus does not calculate Seaport Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Seaport Therapeutics  (NAS:SPTX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Seaport Therapeutics's Interest Expense for the six months ended in Dec. 2025 was $0.00 Mil. Its Operating Income for the six months ended in Dec. 2025 was $-87.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $3.44 Mil.

Seaport Therapeutics's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

GuruFocus does not calculate Seaport Therapeutics's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Seaport Therapeutics Inc has enough cash to cover all of its debt. Its financial situation is stable.

Seaport Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics Interest Expense Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
Interest Expense
0.00 0.00

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
Interest Expense 0.00 0.00
SPTX
11GF Score
Seaport Therapeutics Inc SPTX
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Seaport Therapeutics (SPTX) has a Interest Expense of $ Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Seaport Therapeutics and its competitors.
Is Seaport Therapeutics' Interest Expense too high?
Seaport Therapeutics' current Interest Expense is $ Mil. Overall, Seaport Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Seaport Therapeutics' Interest Expense compare to LXRX and DRTS?
Seaport Therapeutics' Interest Expense of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Seaport Therapeutics and its competitors. Seaport Therapeutics's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seaport Therapeutics stock overvalued right now?
Seaport Therapeutics (SPTX) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Seaport Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Seaport Therapeutics (SPTX), the current Interest Expense is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.43
Price